UBS Group
ABEV icon

UBS Group’s Ambev ABEV Stock Holding History

UBS Group’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,200
Closed -$7K – 8443
2015
Q1 		$7K Hold
1,200
– – ﹤0.01% 7883
2014
Q4 		$7K Buy
+1,200
New +$7.58K ﹤0.01% 8684

Other funds holding ABEV

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $436M AUM 42.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group's ABEV Position: Q1 2026 in Review

UBS Group increased its Ambev (ABEV) stake by 14% in Q1 2026, buying an estimated $2.26M and bringing the position to 6,550,266 shares worth $19.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

UBS Group first reported a position in ABEV in Q4 2014 and has held it in 46 quarters since. The position peaked at $33.7M in Q1 2025. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • UBS Group held 6,550,266 shares of Ambev worth $19.1M as of Q1 2026.
  • UBS Group bought 792,049 Ambev shares in Q1 2026, an estimated $2.26M.
  • Ambev made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2645 holding.
  • UBS Group first reported a position in Ambev in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Ambev position peaked at $33.7M in Q1 2025.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.